5 completed. 5 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 2 | Completed 2 |
Follow Interleukin-7: new trials by email Literature Review of Interleukin-7 trials Research Report on Interleukin-7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II Recombinant Interleukin-7 - Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 1 | 2020-09-29 | 2024-10-17 |
| Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma Atezolizumab, Biopsy, Biospecimen Collection - Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 47 | 2019-06-05 | 2024-07-26 |
| A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients Interleukin-7, Placebo - Severe Sepsis With Septic Shock | Phase 2 | Completed | Revimmune | 27 | 2016-01-01 | 2020-07-09 |
| Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients placebo, interleukin 7 - Metastatic Breast Cancer | Phase 2 | Completed | Centre Leon Berard | 24 | 2011-06-01 | 2015-02-09 |
| Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1) Interleukin-7 - Hepatitis C | Phase 1 / Phase 2 | Completed | Cytheris SA | 10 | 2007-05-01 | 2012-10-18 |
Breast Neoplasms (1) · Carcinoma, Transitional Cell (1) · Hepatitis C (1) · Hepatitis, Chronic (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Liver Diseases (1) · Lymphopenia (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Ureteral Neoplasms (1) · Urethral Neoplasms (1) · Urinary Bladder Neoplasms (1) · Virus Diseases (1)
Centre Leon Berard (1) · Cytheris SA (1) · M.D. Anderson Cancer Center (1) · National Cancer Institute (NCI) (1) · Revimmune (1)
United States (3) · France (2) · Italy (1) · Switzerland (1)
Evan Y Yu (1) · Gheath Al-Atrash (1) · Isabelle Ray Coquart (1) · Tilman Gerlach (1)
PMID 19287090, PMID 10561360, PMID 10737767, PMID 12010786, PMID 12411295, PMID 12519925, PMID 12610500, PMID 12759326, PMID 12816983, PMID 14615453, PMID 15503313, PMID 15569976, PMID 15629410, PMID 15841203, PMID 15905493, PMID 16557261, PMID 16699374, PMID 17135638, PMID 17320482, PMID 18573906, PMID 19244125, PMID 19380868, PMID 19396174, PMID 19424209, PMID 19549917, PMID 19808962, PMID 19933849, PMID 21153402, PMID 21508983, PMID 22187279, PMID 22383042, PMID 22550117, PMID 22693226, PMID 23427891, PMID 24232462, PMID 29515037, PMID 8636781, PMID 9215626, PMID 9657738
P30CA015704 (1), R01CA061508 (1), U01CA154967 (1)